Bartlett HIV/AIDS Review: September 15, 2004 Dr. Bartlett reviews the latest data on TDF vs d4T, FTC vs d4T, EFV vs ATZ, hyperlactatemia after NRTI switch, HAART and sexual risk-taking, cancer risk ...

From the identification of HIV as the agent that causes AIDS, to the development of effective antiretroviral drugs, the scientific achievements in HIV research in the past 20 years have been ...

The conference emphasized advancements in HIV pathogenesis, persistence, and gene therapy, alongside policy and drug use intersections. Lenacapavir was found safe in adolescents, offering new insights ...

At Western University, a bold idea is taking shape: what if lifesaving medical breakthroughs were designed from the very beginning to reach everyone ...

In a first, the study published in the journal Emerging Microbes and Infections demonstrated the team’s patented therapeutic candidate, an HIV-virus-like-particle (HLP), is 100 times more effective ...

The human immunodeficiency virus (HIV) has stubbornly stated that it is here to stay, causing the devastating HIV/AIDS epidemic. Fortunately, human stubbornness and resilience are not in short supply ...

The autophagy process, a critical regulator of T-cell function, has been shown to control acute HIV-1 infection and play a crucial role also in HIV-1 disease pathogenesis. Moreover, previous studies ...

Thumbi Ndung’u consults for Gilead Sciences, Inc. He has received HIV cure-related research grants from Gilead Sciences, Inc, the US NIH, Bill and Melinda Gates Foundation, Wellcome Trust and SFA ...